Surgery News and Research

RSS

Cohera's TissuGlu Surgical Adhesive receives CE Mark approval

Cohera Medical, Inc., a rapidly growing medical device company, announced today that it has received CE Mark approval for its lead product, TissuGlu® Surgical Adhesive. CE Mark approval allows TissuGlu to be sold in the European Union.

14 Sep 2011

Zimmer receives clearance for pediatric use of Universal Clamp Spinal Fixation System

Zimmer Holdings, Inc. announced today that it has received an additional clearance for its proprietary Universal Clamp Spinal Fixation System. A first for the United States, the system is now indicated for treatment of idiopathic and neuromuscular scoliosis in patients eight years of age or older. The Universal Clamp Spinal Fixation System is used in conjunction with spinal fusion surgeries.

14 Sep 2011

Study determines incidence of aortic complications in BAV and general population

While the incidence of the life-threatening condition of aortic dissection is significantly higher than in the general population, it remains low among patients with the congenital heart defect, bicuspid aortic valve; however, the incidence of aortic aneurysms is significantly high, according to a study in the September 14 issue of JAMA.

14 Sep 2011

Bausch + Lomb to launch VICTUS Femtosecond Laser Platform for cataract surgery

Bausch + Lomb, the global leader in eye health, and Technolas Perfect Vision GmbH (TPV), a leading ophthalmology laser company, plan to introduce the VICTUS Femtosecond Laser Platform at the upcoming XXIX Congress of the European Society of Cataract and Refractive Surgeons.

14 Sep 2011

Study finds high prevalence of lymph node evaluation for colon cancer

During the past two decades there has been a significant increase in the percentage of patients who have a high number of lymph nodes evaluated during colon cancer operations, but this improvement is not associated with an increase in the overall proportion of colon cancers that are node positive, according to a study in the September 14 issue of JAMA.

14 Sep 2011

Nanobiotix starts clinical trial of new cancer treatment for soft tissue sarcoma

Nanobiotix, a company developing novel cancer nanotherapeutics, announced today that its lead compound NBTXR3 has received the formal authorization from the French Medicine Agency, AFSSAPS, to start the first clinical trial.

14 Sep 2011

African American patients more likely to receive replacement surgery in low-quality hospitals

Racial minorities have reduced access to high-quality joint replacement care, according to Dr. Xueya Cai and colleagues from the University of Iowa in the US. Their work, published online in Springer's journal Clinical Orthopaedics and Related Research, shows that African American patients are more likely than Caucasians to receive total knee arthroplasty (or replacement surgery) in low-quality hospitals.

14 Sep 2011

Curcumin suppresses cell signaling pathway that drives growth of head and neck cancer

Curcumin, the main component in the spice turmeric, suppresses a cell signaling pathway that drives the growth of head and neck cancer, according to a pilot study using human saliva by researchers at UCLA's Jonsson Comprehensive Cancer Center.

14 Sep 2011

Health Canada approves Afinitor for treatment of brain tumours caused by TSC in children

Families with children suffering from brain tumours caused by an uncommon genetic disorder known as Tuberous Sclerosis Complex (TSC) have new hope with Health Canada's recent conditional approval of a new therapeutic use for the drug Afinitor (everolimus). Afinitor is the first drug therapy approved in Canada for the treatment of brain tumours caused by TSC in patients three years of age and older.

14 Sep 2011

Genetic variant associated with increased long-term mortality risk after coronary artery bypass graft procedure

Duke University Medical Center researchers have found a genetic variant that seems to be associated with lower five-year survival after a coronary artery bypass.

14 Sep 2011

New minimally invasive technique to diagnose early-stage ovarian cancer

By combining three previously unrelated imaging tools into one new device, a team of researchers from the University of Connecticut and the University of Southern California has proposed a new way to diagnose early-stage ovarian cancer in high-risk women through minimally invasive surgery. The new technique may be better than the current standard procedure of preemptively removing the ovaries.

14 Sep 2011

USU, HJF to host 'The TBI Spectrum' symposium on Sept. 22

New Jersey Congressman and former Philadelphia Eagles offensive lineman Jon Runyan and Army Vice Chief of Staff General Peter Chiarelli will deliver keynote addresses at the fourth USU-HJF Military Medicine Symposium, "The TBI Spectrum," Sept. 22, 2011.

14 Sep 2011

Henry Ford study identifies 23 microRNAs for laryngeal cancer

A Henry Ford Hospital study has identified 23 microRNAs for laryngeal cancer, a discovery that could yield new insight into what causes certain cells to grow and become cancerous tumors in the voice box.

14 Sep 2011

AM-Pharma announces €29.2m series D round of financing

AM-Pharma B.V., a biopharmaceutical company focused on the preclinical and clinical development of Alkaline Phosphatase (AP) for treatment of severe inflammatory diseases, today announced that it has raised €29.2m in Series D financing.

13 Sep 2011

Delcath announces updated Phase 2 trial results from metastatic neuroendocrine tumor cohort

Delcath Systems, Inc. announced that updated results from the metastatic neuroendocrine tumor (mNET) cohort of the Company's recently completed Phase 2 clinical trial were presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) congress held this week in Munich, Germany.

13 Sep 2011

George W. Bush Institute forms public-private partnership to combat cervical, breast cancers in developing world

The George W. Bush Institute is forming a public-private partnership to use PEPFAR's existing infrastructure of doctors, nurses and clinics to expand screening and treatment of women for cervical cancer and perform breast cancer education in the developing world, the Wall Street Journal reports.

13 Sep 2011

ASGE Endoscopy Unit Recognition Program honors 21 endoscopy units for safety and quality

The American Society for Gastrointestinal Endoscopy (ASGE) has recognized 21 endoscopy units as part of its program specifically dedicated to promoting quality in endoscopy, in all settings where it is practiced in the United States.

13 Sep 2011

ImmunoCellular announces updated long-term data from ICT-107 Phase I trial on GBM

ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, today announced updated long-term data from a Phase I clinical trial of ICT-107, the Company's lead cancer vaccine candidate for the treatment of glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer.

13 Sep 2011

Transcendental Meditation practice reduces health care costs

According to a study published this week in the September/October 2011 issue of the American Journal of Health Promotion, people with consistently high health care costs experienced a 28 percent cumulative decrease in physician fees after an average of five years practicing the stress-reducing Transcendental Meditation technique compared with their baseline.

12 Sep 2011

Entellus Medical introduces easy-to-use tool for navigating sinus passages

Entellus Medical, a Minnesota-based medical technology company, today announced the launch of its PathAssist™ Light Seeker™ at the annual meeting of the American Academy of Otolaryngology-Head and Neck Surgery in San Francisco.

12 Sep 2011

Surgery News and Research

Cohera's TissuGlu Surgical Adhesive receives CE Mark approval

Zimmer receives clearance for pediatric use of Universal Clamp Spinal Fixation System

Study determines incidence of aortic complications in BAV and general population

Bausch + Lomb to launch VICTUS Femtosecond Laser Platform for cataract surgery

Study finds high prevalence of lymph node evaluation for colon cancer

Nanobiotix starts clinical trial of new cancer treatment for soft tissue sarcoma

African American patients more likely to receive replacement surgery in low-quality hospitals

Curcumin suppresses cell signaling pathway that drives growth of head and neck cancer

Health Canada approves Afinitor for treatment of brain tumours caused by TSC in children

Genetic variant associated with increased long-term mortality risk after coronary artery bypass graft procedure

New minimally invasive technique to diagnose early-stage ovarian cancer

USU, HJF to host 'The TBI Spectrum' symposium on Sept. 22

Henry Ford study identifies 23 microRNAs for laryngeal cancer

AM-Pharma announces €29.2m series D round of financing

Delcath announces updated Phase 2 trial results from metastatic neuroendocrine tumor cohort

George W. Bush Institute forms public-private partnership to combat cervical, breast cancers in developing world

ASGE Endoscopy Unit Recognition Program honors 21 endoscopy units for safety and quality

ImmunoCellular announces updated long-term data from ICT-107 Phase I trial on GBM

Transcendental Meditation practice reduces health care costs

Entellus Medical introduces easy-to-use tool for navigating sinus passages

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News